- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00378859
The Effect of Milk and Meat on IGFs in Prepubertal Boys
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of the study is to examine whether a high protein intake (PI) from either milk or meat, at a level often seen in late infancy, in healthy, prepubertal children can increase fasting levels of serum IGF-I, IGFBP-3 and IGF-I/IGFBP-3 as well as insulin, glucose and HOMA insulin reststance, HOMA beta cell function and amino acids.
IGF-I levels are positively associated with growth velocity in children and some studies suggest that a high animal PI can stimulate growth. During protein deprivation IGF-I decrease, but it is unknown whether a high PI can increase s-IGF-I in well-nourished children.
Insulin is also a growth factor, and studies have found that postprandially, milk possess some insulinotrophic effect not related to its carbohydrate content. However, the effect on fasting insulin in children is unknown.
Design: Twenty-four 8-y-old boys are asked to take either 1.5 l of skimmed milk (n=12) or the same amount of protein as 250 g low fat meat (n=12) daily for seven days. The remaining diet they can choose freely. At baseline and after seven days, anthropometrical variables are measured, diet is registered (3-d weighed records), and the blood analytes are determined after fast.
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Frederiksberg C, Denmark, 1958
- Institute of Human Nutrition, Rolighedsvej 30
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- habital milk intake more than 500 mL/d
- willing to increase intake of milk or meat considerably for one week
Exclusion Criteria:
- chronic illnesses
- children who suffer from any condition likely to affect their protein metabolism or growth
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
IGF-I
|
|
IGFBP-3
|
|
Insulin
|
|
Glucose
|
|
Aminogram
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Urea Nitrogen
|
|
Blood Pressure
|
|
Adiponectin
|
|
Leptin
|
|
Ghrelin
|
|
Osteocalcin
|
|
BAP
|
|
CTX
|
|
Kidney Size
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Kim F Michaelsen, Dr Med Sci, Institute of Human Nutrition, Rolighedsvej 30, DK-1958 Frederiksberg C, Denmark
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KF 01-097/00
- D-110
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.